Bulk funded pharmacy order : iclusig (potatinib) 15MG tablet
Ended Awarded Last action
- Contract number
- VA26017J3080
- Awardee
-
Ariad Pharmaceuticals, Inc. UEI EVMMLCKBZS47
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $79,221
Award facts
- Contract value 100% obligated
- $79,221.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$18,361 | |
| Funding Only Action | -$107,961 | |
| Original award | $205,544 |
About this award
This federal contract award is a BPA (Blanket Purchase Agreement) call issued by the Veterans Health Administration's Veterans Integrated Service Network 20 (VISN 20) to Ariad Pharmaceuticals, Inc. The contract is for the delivery of Iclusig (ponatinib) 15mg tablets, a cancer drug, to the VA medical system. The contract has a ceiling value of $79,221.45 and an ultimate completion date of September 30, 2017. The contract was not set aside and was awarded under the GSA Pharmaceuticals and Drugs schedule. Ariad Pharmaceuticals, Inc. is a pharmaceutical company that specializes in oncology treatments and has previously supplied other cancer drugs like Lenvima to the VA through federal contracts.
Quick answers
Who was awarded contract VA26017J3080?
VA26017J3080 was awarded to Ariad Pharmaceuticals, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2016.
How much is contract VA26017J3080 worth?
The government has obligated $79,221 on VA26017J3080.
Is contract VA26017J3080 an order under another contract?
Yes. VA26017J3080 is a BPA call under V797D50395-VA797P15A0016, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA26017J3080 competed?
The extent of competition for VA26017J3080 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award